RXRA and neoplasm: Interestingly, we found that there is a novel tumor suppressive RXRα-KRT7-AS-PTEN singling axis in cancer cells, and activation of the RXRα-KRT7-AS-PTEN axis is a novel strategy for developing new therapeutics against cancer.